Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oluwafemi G Oluwole

BSc (Hons), MSc, PhD

Genomics Scientist (Molecular & Computational)

  • Femi Oluwole is a geneticist and pharmacologist with broad interests in genomics, drug discovery and drug safety. He has a keen interest in experimental, clinical, and epidemiological research of emerging brain-associated disorders. He is making differences by detecting mutations in cohort studies, measuring gene functions, mapping biological pathways, and utilizing discoveries from multiple disciplines to underpin human phenotype ontologies. He has published up to 25 scientific papers, presented at scientific conferences and won awards. He is a Staff at the University of Oxford, UK, and a Visiting Scholar at the Institute of Infectious Disease and Molecular Medicine (IDM) University of Cape Town, South Africa; And Institutes of Primate Research, Nairobi, Kenya. Femi trained in Africa under the supervision of Profs S. Umukoro, S. Bardien, H. Kuivaniemi, and G. Tromp. He has then co-supervised up to six students to graduation. Between 2019 - 2022, he established his career in the field of genomics while working in Prof A. Wonkam's lab at the University of Cape Town, South Africa. Of note, he is currently a National Research Foundation Y-rated researcher, and an Editor for Open Medicine De gruyter Journal. In addition, Femi has held various administrative positions with outstanding records of service including establishing a non-governmental organization (Absolute Cedars) that promotes technological and human capacity development in marginalized communities. Presently, Femi is leading the effort to investigate the molecular medicine of movement disorders and neuropathic pain in Prof Jenny Taylor's Research Group.

Postdoctoral Scientist

Specific Research Area

Human DNA and variations; Translational genomics (gene-gene, gene-protein, gene-environment) of  emerging brain-associated disorders and neuropathic pain.